IPH5301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPH5301, covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]